Strides Pharma Science Ltd.

NSE: STAR  SECTOR: Pharmaceuticals & Drugs

660.2
+18.95 (2.96%)

Price Summary

Today's High

₹ 666.85

Today's Low

₹ 646.05

52 Week High

₹ 745.15

52 Week Low

₹ 271

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

5917.08633728 Cr.

Enterprise Value

6661.25933728 Cr.

No. of Shares

8.9625664 Cr.

P/E

64.89

P/B

1.86

Face Value

₹ 10

Div. Yield

2.12%

Book Value (TTM)

₹  354.1027

CASH

108.434 Cr.

DEBT

852.607 Cr.

Promoter Holding

31.27%

EPS (TTM)

₹  10.1738

Sales Growth

8.89213093471088%

ROE

3.48043902532502 %

ROCE

5.40099224894317 %

Profit Growth

6.67198678253847 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year8.89%
3 Year6.61%
5 Year12.49%

Profit Growth (in Cr.)

1 Year1.21%
3 Year0.96%
5 Year-26.82%

ROE%

1 Year3.48%
3 Year11.63%
5 Year8.79%

ROCE %

1 Year5.4%
3 Year10.91%
5 Year8.87%

Debt/Equity

0.269008296405207

Price to Cash Flow

39.76

Interest Cover Ratio

3.276287979854

CFO/PAT (5 Yr. Avg.)

1.23996334400569

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2020 31.27 50.93
Dec 2019 31.28 48.2
Sep 2019 31.28 51.29
Jun 2019 31.24 13.02
Mar 2019 31.24 16.31
* Figures given above are % of equity capital

 Strengths

  • The company has a good cash flow management; CFO/PAT stands at 1.23996334400569.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 5.88926132020847.

 Limitations

  • The company has shown a poor profit growth of 0.961816838519636% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.60583658367109% for the Past 3 years.
  • Promoter pledging has increased from 31.27% to 50.93% in 1 quarter.
  • Company has contingent liabilities of 3478.175 Cr.
  • Promoter pledging is high as 50.93%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020
Net Sales 442.53 425.41 364.47 441.74 409.34
Total Expenditure 394.9 361.82 333.98 379.76 386.51
Operating Profit 47.63 63.59 30.49 61.98 22.83
Other Income 23.08 32.2 23.98 27.26 22.84
Interest 17.13 14.88 16.39 18.32 15.77
Depreciation 23.24 22.69 22.55 23.15 23.76
Exceptional Items 0 0 0 0 0
Profit Before Tax 30.34 58.22 15.53 47.77 6.14
Tax 5.66 11.22 1.88 21.4 1.98
Profit After Tax 24.68 47 13.65 26.37 4.16
Adjusted EPS (Rs) 0.28 0.52 0.15 0.29 0.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 2221.63 1381.82 1955.4 1537.44 1674.15
Total Expenditure 1953.73 1269.85 1815.21 1403.1 1464.11
Operating Profit 267.9 111.97 140.2 134.34 210.04
Other Income 109.12 169.06 1001.72 114.61 100.16
Interest 102.62 71.96 81.97 54.09 66.71
Depreciation 102.69 70.01 114.77 83 91.63
Exceptional Items -26.8 -15.16 -29.38 -3.52 0
Profit Before Tax 144.91 123.9 915.8 108.33 151.86
Tax 14.71 15.36 24.21 -2.04 40.16
Net Profit 130.2 108.54 891.59 110.37 111.7
Adjusted EPS (Rs.) 14.57 12.14 99.62 12.32 12.47

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 89.35 89.42 89.5 89.55 89.57
Total Reserves 3068.28 3143.1 3072.52 3167.25 3085.6
Borrowings 861.4 769.45 2.45 0.15 0
Other N/C liabilities 15.15 25.77 -36.86 -63.27 -18.74
Current liabilities 1244.88 1434.16 1104.05 1388.99 1437.79
Total Liabilities 5279.05 5461.9 4231.65 4582.68 4594.21
Assets
Net Block 983.58 1123.76 497.96 496.73 543.31
Capital WIP 126.42 99.63 86.89 72.56 86.03
Investments 1307.94 1310.77 1531.19 2071.47 2242.93
Loans & Advances 154.66 204.05 154.76 223.27 229.83
Other N/C Assets 60.82 144.54 461.31 55.06 35.32
Current Assets 2645.62 2579.16 1499.54 1663.59 1456.8
Total Assets 5279.05 5461.9 4231.65 4582.68 4594.21
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 144.91 123.9 915.8 108.33 151.86
Adjustment 156.46 193.49 -670.77 90.19 119.88
Working Capital Changes -168.93 131.16 -161.75 -121.04 -90.72
Tax Paid -49.36 -36.81 -17.68 -37.52 -32.18
Operating Cash Flow 83.08 411.74 65.59 39.97 148.84
Investing Cash Flow -1063.9 -344.05 447.36 -166.06 50.88
Financing Cash Flow 1570.84 -67.24 -706.77 123.26 -203.56
Net Cash Flow 590.03 0.45 -193.82 -2.83 -3.84

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

Strides Pharma Scien Stock Price Analysis and Quick Research Report. Is Strides Pharma Scien an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Strides Pharma Scien and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 148.838 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Strides Pharma Scien has a Debt to Equity ratio of 0.269008296405207 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Strides Pharma Scien , the EPS growth was 1.18880277207077 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Strides Pharma Scien has OPM of 12.5458367206264 % which is a bad sign for profitability.
     
  • ROE: Strides Pharma Scien have a poor ROE of 3.48043902532502 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Strides Pharma Scien

X